Premium
Retracted : The prevalence of elevated gamma‐glutamyltransferase and sorbitol dehydrogenase activity in racing Thoroughbreds and their associations with viral infection
Author(s) -
Ramsay J. D.,
Evanoff R.,
Mealey R. H.,
Simpson E. L.
Publication year - 2019
Publication title -
equine veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.82
H-Index - 87
eISSN - 2042-3306
pISSN - 0425-1644
DOI - 10.1111/evj.13092
Subject(s) - subclinical infection , sorbitol dehydrogenase , gamma glutamyltransferase , medicine , horse , hepatitis c virus , gastroenterology , population , hepacivirus , virology , immunology , biology , virus , enzyme , paleontology , biochemistry , environmental health
Summary Background In racehorses, serum gamma‐glutamyltransferase (GGT) activity is positively correlated with cumulative days in training and, when ≥100 IU/L, has been associated with poor performance. The prevalence of increased GGT activity in North American Thoroughbreds and its aetiopathogenesis are unknown. Four emerging viruses, pegivirus E (PgV E; equine pegivirus), hepacivirus A (HcV A; equine hepacivirus), pegivirus D (PgV D; Theiler's disease virus), and equine parvovirus‐hepatitis (EqPV‐H) have been identified in horses with clinical and subclinical hepatopathy. Available prevalence data indicate these viruses may commonly infect racehorses and contribute to increased liver enzyme activity in this population. Objectives To investigate the association between viral infection and increased liver enzyme activity in racing Thoroughbreds. Study design Cross‐sectional study. Methods Prerace blood samples were collected from 802 Thoroughbreds and tested for GGT and sorbitol dehydrogenase (SDH) activity, and the presence of PgV E, HcV A, PgV D and EqPV‐H nucleic acid. Results Increased SDH and/or GGT were detected in 56.2% of the 802 serum samples. The infection prevalence and relative risk (RR) of having concurrently increased liver enzyme activity were: PgV E = 18.2% (RR = 0.820, 95% CI = 0.662–0.978, P = 0.03), HcV A = 2.5% (RR = 1.132, 95% CI = 0.719–1.466, P = 0.6), PgV D = 0.5% (RR = 0.875, 95% CI = 0.165–1.598, P>0.9), EqPV‐H = 2.9% (RR = 0.916, 95% CI = 0.564–1.266, P = 0.7). Main limitations Longitudinal samples were not tested. Conclusions While viral infection was common among Thoroughbreds in this study, infection did not explain the high prevalence of increased liver enzyme activity. In fact, PgV E infection was associated with a reduced risk of having increased liver enzyme activity, indicating PgV E is unlikely to be a cause of hepatitis in horses. Importantly, like GGT, increased SDH activity was highly prevalent in this study, and provides additional evidence that hepatocellular injury was occurring in these horses.